RE:RE:RE:CloudMD grants options to buy 700,000 sharesRegardless of whether or not I was quite high at the time I wrote the last post (that's an attempt at something called light humour ... remember humour?), and admittedly did not research the company's history prior to its move to the venture exchange (my bad), my read and opinion (oh my, I have a different opinion, how awful, I should just toe the line and get follow the hordes, no?) remains: DOC analyst promotion has been paid for; management team is third tier at best; company is out of its league when pitted against rivals like Telus, Akira, Maple, eCare, GoEvisit, LiveCare, Wello ... the space is crowded for such a small market country like Canada and demand will fall once pandemic ends; Kohler is a financier in it for a quick buck (look at his background); at best this is a short term trade with a short runway; if the pandemic ends tomorrow, interest in DOC sunstantially lessens, i.e., the interest in DOC, and the ability to quickly raise funds, has been generated only b/c of the pandemic. Will my opinion prove prescient? Time will tell. For now, it's a good time to be in gold wouldn't you say? Regardless of my opinion, what counts for investors is share price. If you're still holding, hang on tight. GLTA.